Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to FRMD4A (FRMD4A-AS1)
- Target
- FRMD4A-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Other
01
Overview
This RNA gene is a long non-coding transcript (lncRNA) that is transcribed from the strand opposite to the protein-coding gene FRMD4A (FERM Domain Containing 4A). As an antisense transcript (FRMD4A-AS1), it has the potential to regulate the expression, stability, or processing of the FRMD4A mRNA through complementary base pairing or by influencing the chromatin environment near the FRMD4A gene locus. General features of antisense lncRNAs include modulation of chromatin state (such as histone acetylation and nucleosome positioning) around the targeted promoter region, which can alter the dynamics of the associated sense transcript by affecting initiation, processing, and stability of the mRNA. No direct drug interactions, biomarkers, or clinical safety concerns are currently documented for this non-coding transcript.
- Other names
- FRMD4A-AS1ENSG00000273474
02
Biological functions
Regulation of gene expressionChromatin remodelingPost-transcriptional regulationPotential modulation of FRMD4A expression
03
Disease associations
Other (no documented direct disease linkage for this particular lncRNA as of search)Antisense lncRNAs in general may be implicated in cancer or other gene-expression-related diseases, but no specific disease roles established for FRMD4A-AS1
Beyond the preview
Go deeper on Novel transcript, antisense to FRMD4A (FRMD4A-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to FRMD4A (FRMD4A-AS1).